
CALCIUM-CHANNEL BLOCKERS AND CICLOSPORIN (CYCLOSPORINE) - LERCANIDIPINE
The plasma levels of lercanidipine were raised 3-fold by ciclosporin, and the ciclosporin AUC was raised by 21% by lercanidipine.
The manufacturers contraindicate concurrent use.
The manufacturers contraindicate concurrent use.